Wenjie Chen344 W 29Th St, Chicago, IL 60616

Mentions for Wenjie Chen

Wenjie Chen resumes & CV records

Resumes

Wenjie Chen

Wenjie Chen

Wenjie Chen

Wenjie Chen

Lead Pv Systems Designer At Solarcity

Position:

Lead PV Systems Designer at SolarCity

Location:

San Mateo, California

Industry:

Renewables & Environment

Work:

SolarCity - San Mateo, CA since Nov 2011
Lead PV Systems Designer SolarCity Aug 2010 - Nov 2011
PV Systems Designer A Squared, NUMMI Contractor Jun 2007 - Apr 2010
QA Engineer TEMECO, Inc Jun 2006 - Dec 2006
HVAC Intern UC Berkeley Graduate School of Education Feb 2006 - May 2006
Research Assistant

Education:

University of California, Berkeley 2003 - 2007
Bachelor of Science, Mechanical Engineering

Skills:

Shanghainese, Mandarin, AutoCAD, Photovoltaics, Lean Manufacturing, Matlab, Microsoft Office, Engineering

Wenjie Chen

Location:

United States

Publications & IP owners

Us Patents

Molecular Targets For Als And Related Disorders

US Patent:

2012014, Jun 7, 2012

Filed:

Dec 7, 2011

Appl. No.:

13/313884

Inventors:

Teepu Siddique - Chicago IL, US
Wenjie Chen - Chicago IL, US
Han-Xiang Deng - Chicago IL, US
Yi Yang - Chicago IL, US

International Classification:

A61K 39/395
A61P 25/28
A61K 48/00
A61K 38/02
G01N 21/64
A61K 31/713

US Classification:

4241301, 435 612, 514 44 A, 514 44 R, 514 177

Abstract:

Provided herein are compositions and methods for diagnosis, risk assessment, research, and therapy related to amyotrophic lateral sclerosis (ALS) and ALS-related disorders. In particular, the present invention relates to mutations in the UBQLN2 gene that cause dominantly inherited chromosome X-linked ALS and ALS/dementia.

Molecular Targets For Als And Related Disorders

US Patent:

2016007, Mar 17, 2016

Filed:

Sep 18, 2015

Appl. No.:

14/858692

Inventors:

- Evanston IL, US
Wenjie Chen - Chicago IL, US
Han-Xiang Deng - Chicago IL, US
Yi Yang - Chicago IL, US

Assignee:

Northwestern University - Evanston IL

International Classification:

C12Q 1/68

Abstract:

Provided herein are compositions and methods for diagnosis, risk assessment, research, and therapy related to amyotrophic lateral sclerosis (ALS) and ALS-related disorders. In particular, the present invention relates to mutations in the UBQLN2 gene that cause dominantly inherited chromosome X-linked ALS and ALS/dementia.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.